THE INVESTIGATIONAL DRUG BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD): EFFICACY ANALYSES FROM THE RECONNECT STUDIES

被引：0
|
作者：
Clayton, A. H. [1 ]
Kingsberg, S. A. [2 ]
Simon, J. [3 ,4 ]
Jordan, R. [5 ]
Lucas, J. [5 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Washington Univ, Washington, DC USA
[4] Womens Hlth & Res Consultants, Washington, DC USA
[5] Palatin Technol Inc, Cranbury, NJ USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2018年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
014
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] CHARACTERIZATION OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN MEN
    DeRogatis, L.
    Rosen, R.
    Goldstein, I
    Werneburg, B.
    Kempthorne-Rawson, J.
    Sand, M.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 334 - 335
  • [22] Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
    Simon, James A.
    Kingsberg, Sheryl A.
    Portman, David
    Williams, Laura A.
    Krop, Julie
    Jordan, Robert
    Lucas, Johna
    Clayton, Anita H.
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (05): : 909 - 917
  • [23] CHARACTERIZATION OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN MEN
    DeRogatis, L.
    Rosen, R. C.
    Goldstein, I
    Werneburg, B.
    Kempthorne-Rawson, J.
    Sand, M.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 184 - 184
  • [24] Characterization of Hypoactive Sexual Desire Disorder (HSDD) in Men
    DeRogatis, Leonard
    Rosen, Raymond C.
    Goldstein, Irwin
    Werneburg, Brian
    Kempthorne-Rawson, Joan
    Sand, Michael
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (03): : 812 - 820
  • [25] The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results
    Koochaki, Patricia
    Revicki, Dennis
    Wilson, Hilary
    Pokrzywinski, Robin
    Jordan, Robert
    Lucas, Johna
    Williams, Laura A.
    Sadiq, Amama
    Krop, Julie
    JOURNAL OF WOMENS HEALTH, 2021, 30 (04) : 587 - 595
  • [26] An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder
    Cipriani, Sarah
    Alfaroli, Chiara
    Maseroli, Elisa
    Vignozzi, Linda
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (01) : 15 - 21
  • [27] BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDERS IN THE RECONNECT STUDIES: ANALYSIS OF BASELINE FREE TESTOSTERONE LEVEL QUARTILE SUBGROUPS
    Clayton, A.
    Simon, J.
    Kingsberg, S.
    Jordan, R.
    Lucas, J.
    Williams, L.
    Krop, J.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (06): : S13 - S14
  • [28] BRAIN DYNAMICS OF FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
    Siewsrichol, W.
    Kaske, E.
    Cacioppo, S.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (06): : S115 - S115
  • [29] Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder
    Borland, Johnathan M.
    Kohut-Jackson, Abigail L.
    Peyla, Anna C.
    Hall, Megan A. L.
    Mermelstein, Paul G.
    Meisel, Robert L.
    NEUROPHARMACOLOGY, 2025, 267
  • [30] The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women
    Pfaus, James G.
    Sadiq, Amama
    Spana, Carl
    Clayton, Anita H.
    CNS SPECTRUMS, 2022, 27 (03) : 281 - 289
12345